42 Years of Care and Ensuring No One Fights Alone!

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)


This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients with progressive NF2 mutated meningiomas.

<< Search Our Articles

Get the Latest NF News & Updates

Sign up to be notified of new posts to our website.


Visit Us
Follow Me
Tweet
Share